The study included 11 healthy, breastfeeding women who had been vaccinated within 6 months after delivery. Out of this group, 5 women had received the Moderna mRNA-1273 vaccine and 6 had received the Pfizer-BioNTech BNT162b2 vaccine. Participants collected and froze breast milk samples before vaccination to establish a baseline and were collected for 5 days after vaccination.